Annual Retained Earnings
-$3.28 B
-$626.60 M-23.58%
31 December 2023
Summary:
PTC Therapeutics annual retained earnings is currently -$3.28 billion, with the most recent change of -$626.60 million (-23.58%) on 31 December 2023. During the last 3 years, it has fallen by -$1.65 billion (-101.59%). PTCT annual retained earnings is now -1210.22% below its all-time high of -$250.61 million, reached on 31 December 2011.PTCT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$3.58 B
-$106.65 M-3.07%
30 September 2024
Summary:
PTC Therapeutics quarterly retained earnings is currently -$3.58 billion, with the most recent change of -$106.65 million (-3.07%) on 30 September 2024. Over the past year, it has dropped by -$453.20 million (-14.49%). PTCT quarterly retained earnings is now -1191.73% below its all-time high of -$277.22 million, reached on 31 December 2012.PTCT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTCT Retained Earnings Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -23.6% | -14.5% |
3 y3 years | -101.6% | -83.2% |
5 y5 years | -249.7% | -221.8% |
PTCT Retained Earnings High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -101.6% | at low | -83.2% | at low |
5 y | 5 years | -249.7% | at low | -221.8% | at low |
alltime | all time | -1210.2% | at low | -1191.7% | at low |
PTC Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$3.58 B(+3.1%) |
June 2024 | - | -$3.47 B(+2.9%) |
Mar 2024 | - | -$3.38 B(+2.8%) |
Dec 2023 | -$3.28 B(+23.6%) | -$3.28 B(+5.0%) |
Sept 2023 | - | -$3.13 B(+4.4%) |
June 2023 | - | -$2.99 B(+7.1%) |
Mar 2023 | - | -$2.80 B(+5.2%) |
Dec 2022 | -$2.66 B(+26.6%) | -$2.66 B(+6.9%) |
Sept 2022 | - | -$2.49 B(+4.6%) |
June 2022 | - | -$2.38 B(+6.8%) |
Mar 2022 | - | -$2.22 B(+6.0%) |
Dec 2021 | -$2.10 B(+28.8%) | -$2.10 B(+7.3%) |
Sept 2021 | - | -$1.95 B(+7.3%) |
June 2021 | - | -$1.82 B(+7.0%) |
Mar 2021 | - | -$1.70 B(+4.5%) |
Dec 2020 | -$1.63 B(+36.8%) | -$1.63 B(+4.8%) |
Sept 2020 | - | -$1.55 B(+4.7%) |
June 2020 | - | -$1.48 B(+13.9%) |
Mar 2020 | - | -$1.30 B(+9.5%) |
Dec 2019 | -$1.19 B(+26.8%) | -$1.19 B(+7.0%) |
Sept 2019 | - | -$1.11 B(+5.7%) |
June 2019 | - | -$1.05 B(+4.1%) |
Mar 2019 | - | -$1.01 B(+7.7%) |
Dec 2018 | -$938.92 M | -$938.92 M(+5.4%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2018 | - | -$890.59 M(+6.1%) |
June 2018 | - | -$839.62 M(+1.1%) |
Mar 2018 | - | -$830.11 M(+2.0%) |
Dec 2017 | -$814.11 M(+10.7%) | -$814.11 M(-0.2%) |
Sept 2017 | - | -$815.38 M(+4.3%) |
June 2017 | - | -$781.64 M(+2.3%) |
Mar 2017 | - | -$764.16 M(+4.0%) |
Dec 2016 | -$735.11 M(+24.0%) | -$735.11 M(+3.8%) |
Sept 2016 | - | -$708.31 M(+5.2%) |
June 2016 | - | -$673.14 M(+6.1%) |
Mar 2016 | - | -$634.23 M(+7.0%) |
Dec 2015 | -$593.00 M(+40.3%) | -$593.00 M(+9.4%) |
Sept 2015 | - | -$542.05 M(+8.7%) |
June 2015 | - | -$498.83 M(+8.3%) |
Mar 2015 | - | -$460.47 M(+9.0%) |
Dec 2014 | -$422.55 M(+28.5%) | -$422.55 M(+6.9%) |
Sept 2014 | - | -$395.28 M(+7.4%) |
June 2014 | - | -$368.00 M(+7.3%) |
Mar 2014 | - | -$342.90 M(+4.3%) |
Dec 2013 | -$328.80 M(+18.6%) | -$328.80 M(+5.8%) |
Sept 2013 | - | -$310.91 M(+1.4%) |
June 2013 | - | -$306.50 M(+5.0%) |
Mar 2013 | - | -$291.91 M(+5.3%) |
Dec 2012 | -$277.22 M(+10.6%) | -$277.22 M |
Dec 2011 | -$250.61 M | - |
FAQ
- What is PTC Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for PTC Therapeutics?
- What is PTC Therapeutics annual retained earnings year-on-year change?
- What is PTC Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for PTC Therapeutics?
- What is PTC Therapeutics quarterly retained earnings year-on-year change?
What is PTC Therapeutics annual retained earnings?
The current annual retained earnings of PTCT is -$3.28 B
What is the all time high annual retained earnings for PTC Therapeutics?
PTC Therapeutics all-time high annual retained earnings is -$250.61 M
What is PTC Therapeutics annual retained earnings year-on-year change?
Over the past year, PTCT annual retained earnings has changed by -$626.60 M (-23.58%)
What is PTC Therapeutics quarterly retained earnings?
The current quarterly retained earnings of PTCT is -$3.58 B
What is the all time high quarterly retained earnings for PTC Therapeutics?
PTC Therapeutics all-time high quarterly retained earnings is -$277.22 M
What is PTC Therapeutics quarterly retained earnings year-on-year change?
Over the past year, PTCT quarterly retained earnings has changed by -$453.20 M (-14.49%)